NCT04721106 2026-02-10Korea Post Marketing Surveillance (PMS) Study of VizimproPfizerCompleted188 enrolled
NCT03755102 2025-05-15A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.Memorial Sloan Kettering Cancer CenterPhase EARLY_PHASE1 Completed17 enrolled